Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07100080
PHASE2/PHASE3

Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)

Sponsor: Bristol-Myers Squibb

View on ClinicalTrials.gov

Summary

A Study of Izalontamab Brengitecan (BMS-986507) versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer after failure of EGFR TKI Therapy

Official title: IZABRIGHT-Lung01: A Randomized, Open-label, Phase 2/3 Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-based Chemotherapy in Patients With EGFR-mutated Non-small Cell Lung Cancer and Disease Progression on EGFR Tyrosine Kinase Inhibitor Therapy

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

500

Start Date

2025-11-05

Completion Date

2030-11-15

Last Updated

2026-10-09

Healthy Volunteers

No

Interventions

DRUG

Iza-bren

Specified dose on specified days

DRUG

Carboplatin

Specified dose on specified days

DRUG

Cisplatin

Specified dose on specified days

DRUG

Pemetrexed

Specified dose on specified days

Locations (187)

UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care building

Irvine, California, United States

University of California, Irvine (UCI) Health - UC Irvine Medical Center

Orange, California, United States

Shaw Cancer Center

Edwards, Colorado, United States

Local Institution - 0085

Gainesville, Florida, United States

Local Institution - 0142

Pembroke Pines, Florida, United States

Piedmont Healthcare

Atlanta, Georgia, United States

John B Amos Cancer Center

Columbus, Georgia, United States

Rush University Medical Center

Chicago, Illinois, United States

Dana-Farber Cancer Institute

Boston, Massachusetts, United States

Washington University School of Medicine

St Louis, Missouri, United States

Renown Regional Medical Center

Reno, Nevada, United States

Perlmutter Cancer Center at NYU Langone Hospital - Long Island

Mineola, New York, United States

NYU Langone Health

New York, New York, United States

Weill Cornell Medical College

New York, New York, United States

Rochester General Hospital Infectious Disease

Rochester, New York, United States

University Hospitals Cleveland Medical Center

Cleveland, Ohio, United States

The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive C

Columbus, Ohio, United States

Providence Cancer Institute Franz Clinic

Portland, Oregon, United States

Providence St. Vincent Medical Center

Portland, Oregon, United States

Oregon Health and Science University

Portland, Oregon, United States

Hospital of the University of Pennsylvania

Philadelphia, Pennsylvania, United States

West Penn Allegheny Health

Pittsburgh, Pennsylvania, United States

Local Institution - 0268

Chattanooga, Tennessee, United States

Tennessee Oncology

Nashville, Tennessee, United States

Local Institution - 0025

Houston, Texas, United States

Local Institution - 0173

San Antonio, Texas, United States

University of Virginia Health System

Charlottesville, Virginia, United States

Virginia Commonwealth University (Vcu)

Richmond, Virginia, United States

Instituto Alexander Fleming

Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina

Hospital Italiano de Buenos Aires

ABB, Buenos Aires F.D., Argentina

Hospital Privado Universitario de Córdoba

Córdoba, Argentina

Local Institution - 0280

Wilrijk, Antwerpen, Belgium

Local Institution - 0161

Auderghem, Bruxelles-Capitale, Région de, Belgium

Local Institution - 0022

Yvoir, Namur, Belgium

Local Institution - 0023

Ghent, Oost-Vlaanderen, Belgium

Local Institution - 0024

Sint-Niklaas, Oost-Vlaanderen, Belgium

Arthur J. E. Child Comprehensive Cancer Centre

Calgary, Alberta, Canada

Princess Margaret Cancer Centre

Toronto, Ontario, Canada

Local Institution - 0184

Chicoutimi, Quebec, Canada

Local Institution - 0185

Montreal, Quebec, Canada

Orlandi Oncologia

Santiago, Santiago Metropolitan, Chile

FALP

Santiago, Santiago Metropolitan, Chile

Bradfordhill

Santiago, Santiago Metropolitan, Chile

Local Institution - 0244

Beijing, Beijing Municipality, China

Local Institution - 0259

Chongqing, Chongqing Municipality, China

Fujian Cancer Hospital

Fuzhou, Fujian, China

Jiangmen Center Hospital

Jiangmen, Guangdong, China

Local Institution - 0271

Anyang, Henan, China

Local Institution - 0261

Luoyang, Henan, China

Local Institution - 0267

Jingzhou, Hubei, China

Tongji Hospital, Tongji Medical College, Huazhong University of Science & Technology

Wuhan, Hubei, China

Local Institution - 0255

Changsha, Hunan, China

Local Institution - 0256

Xuzhou, Jiangsu, China

Local Institution - 0247

Nanchang, Jiangxi, China

Local Institution - 0246

Changchun, Jilin, China

Local Institution - 0257

Shenyang, Liaoning, China

Local Institution - 0248

Jinan, Shandong, China

Local Institution - 0250

Shanghai, Shanghai Municipality, China

Local Institution - 0249

Shanghai, Shanghai Municipality, China

Shanxi Cancer Hospital

Taiyuan, Shanxi, China

Local Institution - 0252

Hangzhou, Zhejiang, China

Local Institution - 0251

Linhai, Zhejiang, China

Local Institution - 0260

Nanning, China

Local Institution - 0229

Valledupar, Cesar Department, Colombia

Local Institution - 0228

Bogotá, Cundinamarca, Colombia

Local Institution - 0227

Montería, Departamento de Córdoba, Colombia

Local Institution - 0226

Cali, Valle del Cauca Department, Colombia

Local Institution - 0014

Strasbourg, Alsace, France

Local Institution - 0017

Toulouse, Haute-Garonne, France

Local Institution - 0010

Lille, Hauts-de-France, France

Local Institution - 0018

La Tronche, Isère, France

Local Institution - 0170

Saint-Herblain, Loire-Atlantique, France

Local Institution - 0162

Bron, Rhône, France

Local Institution - 0019

Villejuif, Val-de-Marne, France

Local Institution - 0012

Marseille, France

Local Institution - 0278

Nantes, France

Local Institution - 0011

Paris, France

Local Institution - 0015

Paris, France

Local Institution - 0207

Esslingen am Neckar, Baden-Wurttemberg, Germany

Local Institution - 0238

Esslingen am Neckar, Baden-Wurttemberg, Germany

Local Institution - 0212

Stuttgart, Baden-Wurttemberg, Germany

Local Institution - 0236

Donauwörth, Bavaria, Germany

Local Institution - 0209

Oldenburg, Lower Saxony, Germany

Local Institution - 0213

Cologne, North Rhine-Westphalia, Germany

Local Institution - 0208

Chemnitz, Saxony, Germany

Local Institution - 0274

Kiel, Schleswig-Holstein, Germany

Local Institution - 0211

Berlin, Germany

Local Institution - 0215

Gauting, Germany

Local Institution - 0242

Hamburg, Germany

Local Institution - 0210

Heidelberg, Germany

Local Institution - 0239

Kassel, Germany

Local Institution - 0241

Ulm, Germany

Local Institution - 0054

Athens, Attikí, Greece

Local Institution - 0060

Chaïdári, Attikí, Greece

Local Institution - 0056

Thessaloniki, Kentrikí Makedonía, Greece

Local Institution - 0062

Thessaloniki, Thessaloníki, Greece

Local Institution - 0083

Ahmedabad, Gujarat, India

Local Institution - 0073

Ahmedabad, Gujarat, India

Local Institution - 0072

Gurugram, Haryana, India

Local Institution - 0069

Bengaluru, Karnataka, India

And 87 more locations on ClinicalTrials.gov